VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

MacroGenics, Inc. (MGNX) Total Return Calculator with Dividends Reinvested

MacroGenics, Inc.

Popular:

The total return for MacroGenics, Inc. (MGNX) stock is +104.76% over the past 12 months. So far it's up 86.96% this year. The 5-year total return is -90.55%, meaning $10,000 invested in MGNX stock 5 years ago would be worth $945 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in MGNX 1 year ago, it would be worth $20,476 today — you'd have gained $10,476.

With Dividends Reinvested$20,476+104.76%

Price Only (No DRIP)$20,476+104.76%

Period2025-05-06 → 2026-05-06

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in MGNX

1Y$20,476+$10,476 (+104.8%)104.8% CAGR

3Y$4,157-$5,843 (-58.4%)-25.4% CAGR

5Y$945-$9,055 (-90.6%)-37.6% CAGR

10Y$1,658-$8,342 (-83.4%)-16.4% CAGR

15Y$1,204-$8,796 (-88.0%)-13.2% CAGR

20Y$1,204-$8,796 (-88.0%)-10.0% CAGR

30Y$1,204-$8,796 (-88.0%)-6.8% CAGR

MacroGenics, Inc. did not pay dividends during this period. Total return = price return.

Loading MGNX total return...

As of 2026-05-06

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	+86.96%	—	+86.96%	—	$18,696
1Y	+104.76%	104.76%	+104.76%	—	$20,476
3Y	-58.43%	-25.36%	-58.43%	—	$4,157
5Y	-90.55%	-37.62%	-90.55%	—	$945
10Y	-83.42%	-16.45%	-83.42%	—	$1,658
15Y	-87.96%	-13.16%	-87.96%	—	$1,204
20Y	-87.96%	-10.04%	-87.96%	—	$1,204
30Y	-87.96%	-6.81%	-87.96%	—	$1,204

Risk & Highlights

Best Year+112.06%2020

Worst Year-68.07%2024

Max Drawdown-34.16%2025-10-21 → 2025-12-08 · Recovered 2026-03-04

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	+23.60%	+23.60%	—	+0.41%	+23.2pp
2025	-51.21%	-51.21%	—	+16.64%	-67.9pp
2024	-68.07%	-68.07%	—	+24.00%	-92.1pp
2023	+51.26%	+51.26%	—	+24.81%	+26.4pp
2022	-60.30%	-60.30%	—	-19.95%	-40.4pp

MGNX outperformed the S&P 500 by 73.44pp over the past year (+104.76% vs +31.32%).

Loading summary...

MGNX Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
MGNXMacroGenics, Inc.	$191M	-5.3%	+87.0%	+104.8%	—	-58.4%	-90.6%	-83.4%
RCUSArcus Biosciences, Inc.	$2.6B	+16.9%	+11.6%	+220.2%	—	+31.0%	-13.7%	+52.9%
FATEFate Therapeutics, Inc.	$264M	+92.4%	+131.3%	+139.1%	—	-58.0%	-97.0%	+33.9%
IMVTImmunovant, Inc.	$5.8B	+15.2%	+10.7%	+107.2%	—	+48.4%	+73.9%	+188.1%
XNCRXencor, Inc.	$954M	+4.6%	-12.8%	+53.8%	—	-52.4%	-67.2%	+14.8%
AGENAgenus Inc.	$137M	+3.2%	+20.4%	+31.0%	—	-87.8%	-93.1%	-93.5%
MRUSMerus N.V.	$6.8B	—	+0.0%	+128.1%	—	+350.2%	+343.6%	+796.4%
ZYMEZymeworks Inc.	$2.1B	+6.8%	+3.7%	+135.2%	—	+215.2%	-6.4%	+112.4%
ABBVAbbVie Inc.	$362.6B	-0.8%	-9.1%	+13.1%	+3.6pp	+52.0%	+102.8%	+306.7%
REGNRegeneron Pharmaceuticals, Inc.	$74.9B	-5.5%	-7.0%	+29.7%	+0.6pp	-3.6%	+45.4%	+96.0%
AMGNAmgen Inc.	$178.7B	-3.3%	+1.8%	+26.0%	+3.6pp	+52.8%	+48.7%	+161.5%

Compare:MGNX vs RCUS MGNX vs FATE MGNX vs IMVT MGNX vs RCUS vs FATE

About MGNX Dividend Returns

MacroGenics, Inc. (MGNX) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of MGNX over the past year?

MacroGenics, Inc. (MGNX) delivered a return of 104.76% over the past year. Since MGNX does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in MGNX be worth today?

A $10,000 investment in MacroGenics, Inc. one year ago would be worth $20,476 today, representing a gain of $10,476.

Q3Does MGNX pay dividends?

MacroGenics, Inc. (MGNX) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For MGNX, the total return equals the price-only return.

Q4Did MGNX beat the S&P 500?

Yes, MacroGenics, Inc. (MGNX) outperformed the S&P 500 by 73.44 percentage points over the past year. MGNX delivered a total return of 104.76%, compared to the S&P 500's 31.32%. This 73.44pp alpha means investors in MGNX earned more than a passive S&P 500 index fund.

Q5What is MGNX's worst drawdown?

MacroGenics, Inc. (MGNX) experienced a maximum drawdown of -34.16% over the past year, declining from its peak on 2025-10-21 to its trough on 2025-12-08. The stock recovered to its prior peak by 2026-03-04. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is MGNX's long-term total return over 10, 20, or 30 years?

Here are MacroGenics, Inc. (MGNX)'s long-term returns with dividends reinvested. Over 10 years, the total return is -83.4% (-16.4% CAGR) — $10,000 would have grown to $1,658. Over 20 years: -88.0% total return (-10.0% CAGR) — $10,000 → $1,204. Over 30 years: -88.0% total return (-6.8% CAGR) — $10,000 → $1,204. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was MGNX's best and worst year?

MacroGenics, Inc.'s best calendar year was 2020 with a total return of 112.1%. Its worst year was 2024 with a total return of -68.1%. This range shows the volatility investors should expect — the difference between the best and worst year is 180.1 percentage points.